Cancer Research Landon Prizes for Basic and Translational Cancer Research  AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 52, 2806-2812, May 15, 1992]
© 1992 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lu, X.
Right arrow Articles by Arthur, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lu, X.
Right arrow Articles by Arthur, G.

Perturbations of Cellular Acylation Processes by the Synthetic Alkyl-lysophospholipid 1-O-Octadecyl-2-O-methylglycero-3-phosphocholine Do Not Correlate with Inhibition of Proliferation of MCF7 and T84 Cell Lines1

Xiaoli Lu and Gilbert Arthur2

Department of Biochemistry and Molecular Biology, Faculty of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada

We have investigated the hypothesis that the antiproliferative effect of 1-O-octadecyl-2-O-methylglycero-3-phosphocholine (ET-18-OCH3) is mediated through the inhibition of cellular acylation processes that control the unsaturated fatty acid complement of phospholipids. The effect of ET-18-OCH3 on the incorporation of radiolabeled oleic, linoleic, and arachidonic acids into MCF7 and T84 phospholipids was investigated. Incubation of MCF7 cells with fatty acids and 2.75 µg/ml ET-18-OCH3, which inhibited the proliferation of the cells after 8 h, resulted in decreased incorporation of fatty acids into a number of phospholipids, notably phosphatidylcholine; however, increased incorporation of fatty acids into other phospholipids was also observed. After 12 h incubation with the alkyl-lysophospholipid, differences in the distribution of newly incorporated fatty acids into the phospholipid classes were observed without any effect on the total amount of fatty acid incorporated. Incubation of MCF7 cells with 5 µg/ml ET-18-OCH3, which caused a cessation in proliferation, had a similar effect on the incorporation of the fatty acids into the phospholipids, but the redistribution of newly incorporated fatty acids in the phospholipids was accompanied by a decrease in the amount of associated radiolabeled fatty acid. Incubation of T84 cells with the labeled fatty acids and 3.5 µg/ml ET-18-OCH3, which significantly decreased proliferation after 8 h, resulted in decreased incorporation of oleic acid into phosphatidylcholine and increased incorporation of oleic, linoleic, and arachidonic acids into phosphatidylethanolamine, prior to the decrease in proliferation. After 12 h incubation with alkyl-lysophospholipid, significant increases in the total amount of labeled oleic and arachidonic acids incorporated in the phospholipid fraction were observed. These results clearly indicate that the antiproliferative effect of ET-18-OCH3 in MCF7 and T84 cells is not dependent on inhibition of acylation processes and the above hypothesis may not be applicable to all alkyl-lysophospholipid-sensitive cells.

1 This work was supported by funds from the National Cancer Institute of Canada and a Medical Research Council Scholarship to G. A.

2 To whom requests for reprints should be addressed, at Department of Biochemistry and Molecular Biology, Faculty of Medicine, University of Manitoba, 770 Bannatyne Avenue, Winnipeg, Manitoba, Canada R3E OW3.

Received 11/ 4/91. Accepted 3/ 9/92.




This article has been cited by other articles:


Home page
Cancer Res.Home page
P. Samadder and G. Arthur
Decreased Sensitivity to 1-O-Octadecyl-2-O-methyl-glycerophosphocholine in MCF-7 Cells Adapted for Serum-free Growth Correlates with Constitutive Association of Raf-1 with Cellular Membranes
Cancer Res., October 1, 1999; 59(19): 4808 - 4815.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
C. Gajate, A. Santos-Beneit, M. Modolell, and F. Mollinedo
Involvement of c-Jun NH2-Terminal Kinase Activation and c-Jun in the Induction of Apoptosis by the Ether Phospholipid 1-O-Octadecyl-2-O-methyl-rac-glycero-3-phosphocholine
Mol. Pharmacol., April 1, 1998; 53(4): 602 - 612.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1992 by the American Association for Cancer Research.